Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by enriquesuave


V.TLT

RE:RE:RE:RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?

Completely agree Eoganacht!  Either the FDA BTD status which will give...

January 29, 2024

V.TLT

RE:RE:2 things

Urologists should like it even more as well.  They can treat 7-9...

January 28, 2024

V.TLT

RE:2 things

Big Pharma will be able to charge the same amount with Ruvidar with way less...

January 28, 2024

V.TLT

RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?

Yes great comparison and I would also like to see how our durable CR rate...

January 27, 2024

V.TLT

RE:RE:RE:RE:RE:CG Oncology IPO Today

I think they are giving another induction phase of 6 treatments for initial...

January 26, 2024

V.TLT

RE:CG Oncology IPO Today

If SP went up to $35, that would be a $3 Billion MC.  Our equivalent SP...

January 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat?

Incredible how CG is IPO'd at a Market Cap of $1.5 Billion US when they...

January 25, 2024

V.TLT

RE:Licensing Deal

https://www.globenewswire.com/news-release/2023/07/10/2701468/0/en/NANOBIOTIX...

January 23, 2024

V.TLT

Licensing Deal

Nanobiotix signed a deal with Janssen in June. $30 Million upfront and...

January 23, 2024

V.TLT

RE:Is a 25% No Response rate inevitable ?

Nice post!  I agree, that eventually 90-100% of patients can get a...

January 23, 2024

V.TLT

RE:RE:RE:RE:RE:Multiple

BTD and a licensing deal to follow should really move us up IMO ...

January 16, 2024

V.TLT

RE:RE:RE:RE:Multiple

I wouldn't trust any numbers from these guys.  Once we get a Big...

January 16, 2024

V.TLT

RE:RE:RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Ruvidar by far given the much lower frequency of treatments 1-3 Vs many more...

January 9, 2024

V.TLT

RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

The constant need for maintenance treatments leads one to deduct that they...

January 9, 2024

V.TLT

RE:RE:RE:TAR-200 and other

Nice chart, but I was using a December 5th article on 30 patients and they...

January 4, 2024

V.TLT

RE:TAR-200 and other

7 months later from my 1st post on TAR200  Company reported still only 6...

January 4, 2024

V.TLT

RE:J & J Granted BTD for treatment of NMIBC using TAR-200

In May, company reported an initial CR of 72% at 3 months (16 out of 22...

January 4, 2024

V.TLT

RE:RE:RE:bid and ask (manipulation? who knows)

Great post Dawg!

December 20, 2023

V.TLT

RE:RE:RE:RE:RE:Next raise after pre-BTD submission

Panic or tax loss selling!  Kind of stupid now, but who knows

December 15, 2023

V.TLT

RE:RE:RE:cretostimogene results DESTROYING US

Remove all personal bias and tell us which treatment would you choose?  ...

December 13, 2023

Featured Company